Nucleic Acids Research, 2002, Vol. 30, No. 13 2930-2939
© 2002 Oxford University Press
On the epigenetic regulation of the human reelin promoter
Psychiatric Institute, Department of Psychiatry, 1601 West Taylor Street, M/C 912 and 1 Department of Molecular Genetics, College of Medicine, University of Illinois, Chicago, IL 60612, USA
Reln mRNA and protein levels are reduced by 
50% in various cortical structures of post-mortem brain from patients diagnosed with schizophrenia or bipolar illness with psychosis. To study mechanisms responsible for this down-regulation, we have analyzed the promoter of the human reelin gene. We show that the reelin promoter directs expression of a reporter construct in multiple human cell types: neuroblastoma cells (SHSY5Y), neuronal precursor cells (NT2), differentiated neurons (hNT) and hepatoma cells (HepG2). Deletion constructs confirmed the presence of multiple elements regulating Reln expression, although the promoter activity is promiscuous, i.e. activity did not correlate with expression of the endogenous gene as reflected in terms of reelin mRNA levels. Co-transfection of the –514 bp human reelin promoter with either Sp1 or Tbr1 demonstrated that these transcription factors activate reporter expression by 6- and 8.5-fold, respectively. Within 400 bp of the RNA start site there are 100 potential CpG targets for DNA methylation. Retinoic acid (RA)-induced differentiation of NT2 cells to hNT neurons was accompanied by increased reelin expression and by the appearance of three DNase I hypersensitive sites 5' to the RNA start site. RA-induced differentiation was also associated with demethylation of the reelin promoter. To test if methylation silenced reelin expression, we methylated the promoter in vitro prior to transfection. In addition, we treated NT2 cells with the methylation inhibitor aza-2'-deoxycytidine and observed a 60-fold increase in reelin mRNA levels. The histone deacetylase inhibitors trichostatin A (TSA) and valproic acid also induced expression of the endogenous reelin promoter, although TSA was considerably more potent. These findings indicate that one determinant responsible for regulating reelin expression is the methylation status of the promoter. Our data also raise the interesting possibility that the down-regulation of reelin expression documented in psychiatric patients might be the consequence of inappropriate promoter hypermethylation.
* To whom correspondence should be addressed. Tel: +1 312 413 4577; Fax: +1 312 413 4569; Email: dgrayson{at}psych.uic.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kundakovic, Y. Chen, A. Guidotti, and D. R. Grayson The Reelin and GAD67 Promoters Are Activated by Epigenetic Drugs That Facilitate the Disruption of Local Repressor Complexes Mol. Pharmacol., February 1, 2009; 75(2): 342 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Oh and A. Petronis Environmental Studies of Schizophrenia Through the Prism of Epigenetics Schizophr Bull, November 1, 2008; 34(6): 1122 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kundakovic, Y. Chen, E. Costa, and D. R. Grayson DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes Mol. Pharmacol., March 1, 2007; 71(3): 644 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Levenson DNA (Cytosine-5) Methyltransferase Inhibitors: A Potential Therapeutic Agent for Schizophrenia Mol. Pharmacol., March 1, 2007; 71(3): 635 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Schanen Epigenetics of autism spectrum disorders Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R138 - R150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rodenhiser and M. Mann Epigenetics and human disease: translating basic biology into clinical applications Can. Med. Assoc. J., January 31, 2006; 174(3): 341 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dong, R. C. Agis-Balboa, M. V. Simonini, D. R. Grayson, E. Costa, and A. Guidotti Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia PNAS, August 30, 2005; 102(35): 12578 - 12583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Veldic, A. Guidotti, E. Maloku, J. M. Davis, and E. Costa In psychosis, cortical interneurons overexpress DNA-methyltransferase 1 PNAS, February 8, 2005; 102(6): 2152 - 2157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mey and P. Mccaffery Retinoic Acid Signaling in the Nervous System of Adult Vertebrates Neuroscientist, October 1, 2004; 10(5): 409 - 421. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Tremolizzo, A. Senna, and V. Rodriguez-Menendez Epigenetic Modulation for Reparative Dentinogenesis? Journal of Dental Research, March 1, 2004; 83(3): 198 - 198. [Full Text] [PDF]
|
|
|
|
|
|
M. Veldic, H. J. Caruncho, W. S. Liu, J. Davis, R. Satta, D. R. Grayson, A. Guidotti, and E. Costa DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains PNAS, January 6, 2004; 101(1): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fujii, R. Z. Luo, J. Yuan, M. Kadota, M. Oshimura, S. R. Dent, Y. Kondo, J.-P. J. Issa, R. C. Bast Jr, and Y. Yu Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation Hum. Mol. Genet., August 1, 2003; 12(15): 1791 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Detich, V. Bovenzi, and M. Szyf Valproate Induces Replication-independent Active DNA Demethylation J. Biol. Chem., July 18, 2003; 278(30): 27586 - 27592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Costa, D. R. Grayson, and A. Guidotti Epigenetic Downregulation of GABAergic Function in Schizophrenia: Potential for Pharmacological Intervention? Mol. Interv., June 1, 2003; 3(4): 220 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tremolizzo, G. Carboni, W. B. Ruzicka, C. P. Mitchell, I. Sugaya, P. Tueting, R. Sharma, D. R. Grayson, E. Costa, and A. Guidotti An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability PNAS, December 24, 2002; 99(26): 17095 - 17100. [Abstract] [Full Text] [PDF]
|
|